Drug Targeting a Gonococcal Virulence Factor Exploits Host Antimicrobial Peptides in Clearance of Infection

J Infect Dis. 2020 Oct 13;222(10):1585-1586. doi: 10.1093/infdis/jiaa439.

Author

William M Shafer^{1

2

3}

Affiliations

¹ Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
² Emory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, Georgia, USA.
³ Laboratories of Bacterial Pathogenesis, Veterans Affairs Medical Center, Decatur, Georgia, USA.

No abstract available

Keywords: Gonorrhea; drugs; infection; lipooligosaccharide; sialic acid; therapy.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Kommentar

MeSH terms

Cathelicidins*
Cytidine Monophosphate
Drug Delivery Systems
Gonorrhea* / drug therapy
Humans
Neisseria gonorrhoeae
Pore Forming Cytotoxic Proteins
Virulence Factors

Substances

Cathelicidins
Pore Forming Cytotoxic Proteins
Virulence Factors
Cytidine Monophosphate

Grants and funding